Investigating causality in the association between 25(OH)D and schizophrenia

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Taylor, Amy E ^a   Burgess, Stephen ^a,b   Ware, Jennifer J ^a   Gage, Suzanne H ^a   Richards, J Brent ^c,d,e   Davey Smith, George ^a   Munafò, Marcus R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25-HYDROXYVITAMIN D; VITAMIN D;

ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; COMPLICATION; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MALE; MENDELIAN RANDOMIZATION ANALYSIS; META ANALYSIS (TOPIC); ODDS RATIO; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; META-ANALYSIS AS TOPIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; VITAMIN D;

EID: 84971291496     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26496     Document Type: Article

References (45)

1. Eyles, D. W., Burne, T. H. & McGrath, J. J. Vitamin D, efects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 34, 47-64 (2013).
2. Valipour, G., Saneei, P. & Esmaillzadeh, A. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab 99, 3863-72 (2014).
3. Belvederi Murri, M. et al. Vitamin D and psychosis: mini meta-analysis. Schizophr Res 150, 235-9 (2013).
4. McGrath, J. Is it time to trial vitamin D supplements for the prevention of schizophrenia? Acta Psychiatr Scand 121, 321-4 (2010).
5. McGrath, J. et al. Vitamin D supplementation during the frst year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 67, 237-45 (2004).
6. Hedelin, M. et al. Dietary intake of fsh, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33, 000 women from the general population. BMC Psychiatry 10, 38 (2010).
7. Vimaleswaran, K. S. et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. Plos Med 10, e1001383 (2013).
8. Voortman, T. et al. Vitamin D defciency in school-age children is associated with sociodemographic and lifestyle factors. J Nutr 145, 791-8 (2015).
9. Saraceno, B., Levav, I. & Kohn, R. The public mental health signifcance of research on socio-economic factors in schizophrenia and major depression. World Psychiatry 4, 181-5 (2005).
10. McNamee, L., Mead, G., MacGillivray, S. & Lawrie, S. M. Schizophrenia, poor physical health and physical activity: evidence-based interventions are required to reduce major health inequalities. Br J Psychiatry 203, 239-41 (2013).
11. Peet, M. Diet, diabetes and schizophrenia: review and hypothesis. Br J Psychiatry Suppl 47, S102-5 (2004).
12. McGrath, J. J. & Lawlor, D. A. The search for modifable risk factors for schizophrenia. Am J Psychiatry 168, 1235-8 (2011).
13. Pedersen, C. B. & Mortensen, P. B. Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry 58, 1039-46 (2001).
14. Davey Smith, G. & Ebrahim, S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32, 1-22 (2003).
15. Davey Smith, G. Mendelian Randomization for Strengthening Causal Inference in Observational Studies: Application to Gene x Environment Interactions. Perspectives on Psychological Science 5, 527-545 (2010).
16. Wang, T. J. et al. Common genetic determinants of vitamin D insufciency: a genome-wide association study. Lancet 376, 180-8 (2010).
17. Ahn, J. et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19, 2739-45 (2010).
18. Berry, D. J., Vimaleswaran, K. S., Whittaker, J. C., Hingorani, A. D. & Hypponen, E. Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D. Plos One 7, e37465 (2012).
19. Ye, Z. et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 3, 35-42 (2015).
20. Leong, A. et al. The causal efect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization study. Plos Med 11, e1001751 (2014).
21. Mokry, L. E. et al. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study. Plos Med doi: 10.1371/journal. pmed.1001866 (2015).
22. Afzal, S., Brondum-Jacobsen, P., Bojesen, S. E. & Nordestgaard, B. G. Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts. BMJ 349, g6330 (2014).
23. Vimaleswaran, K. S. et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol 2, 719-29 (2014).
24. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-7 (2014).
25. Power, R. A. et al. Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nat Neurosci 18, 953-5 (2015).
26. Agerbo, E. et al. Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysis. JAMA Psychiatry 72, 635-41 (2015).
27. Power, R. A. et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry 19, 1201-4 (2014).
28. Pierce, B. L. & Burgess, S. Efcient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 178, 1177-84 (2013).
29. Burgess, S. et al. Using published data in Mendelian randomization: a blueprint for efcient identifcation of causal risk factors. Eur J Epidemiol 30, 543-52 (2015).
30. Tomas, D. C., Lawlor, D. A. & Tompson, J. R. Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al. Ann Epidemiol 17, 511-3 (2007).
31. Burgess, S., Butterworth, A. & Tompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37, 658-65 (2013).
32. Powe, C. E. et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369, 1991-2000 (2013).
33. Moon, M. et al. Vitamin D-binding protein interacts with A beta and suppresses A beta-mediated pathology. Cell Death and Diferentiation 20, 630-638 (2013).
34. Rinaldi, A. O. et al. Increased Circulating Levels of Vitamin D Binding Protein in MS Patients. Toxins 7, 129-137 (2015).
35. Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: efect estimation and bias detection through Egger regression. Int J Epidemiol 44, 512-25 (2015).
36. Spiro, A. & Buttriss, J. L. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull 39, 322-350 (2014).
37. Wacker, M. & Holick, M. F. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol 5, 51-108 (2013).
38. Nerhus, M. et al. Vitamin D status in psychotic disorder patients and healthy controls-The infuence of ethnic background. Psychiatry Res 230, 616-21 (2015).
39. VanderWeele, T. J., Tchetgen Tchetgen, E. J., Cornelis, M. & Kraf, P. Methodological challenges in mendelian randomization. Epidemiology 25, 427-35 (2014).
40. McGrath, J. J. et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch Gen Psychiatry 67, 889-94 (2010).
41. McGrath, J. J., Burne, T. H., Feron, F., Mackay-Sim, A. & Eyles, D. W. Developmental vitamin D defciency and risk of schizophrenia: a 10-year update. Schizophr Bull 36, 1073-8 (2010).
42. Poulton, R. et al. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry 57, 1053-8 (2000).
43. Kendler, K. S., McGuire, M., Gruenberg, A. M. & Walsh, D. Examining the validity of DSM-III-R schizoafective disorder and its putative subtypes in the Roscommon Family Study. Am J Psychiatry 152, 755-64 (1995).
44. van Os, J., Linscott, R. J., Myin-Germeys, I., Delespaul, P. & Krabbendam, L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 39, 179-95 (2009).
45. Zammit, S. et al. Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry 170, 742-50 (2013).